uBibliorum
Repositório Digital da Universidade da Beira Interior
Entradas recentes
Characterization of Effector-Memory CD8+ T cells and their Association with Human Cognitive Function
Publication . Esgalhado, André João Gabriel ; Arosa, Fernando Aguilar; Uhrberg, Markus
Human effector-memory CD8+ T cells consist of highly differentiated cells that differ in the expression of the tyrosine phosphatase isoform CD45RA, being designated as CD8+ TEM and CD8+ TEMRA cells. These highly heterogeneous and polyfunctional cells possess cytotoxic, regulatory, and suppressive features, and are capable of migrating to non-lymphoid tissues and organs, including the brain under certain conditions. Expansions of CD8+ TEM and CD8+ TEMRA cells have been described in chronic inflammatory diseases, tumors and viral infections, as well as in healthy elderly individuals, including centenarians. Over the past few decades, the role of CD8+ T cells, particularly CD8+ TEMRA cells, has been the subject of several studies in the context of aging, cognition, and neurodegeneration, where they have been generally regarded as detrimental to the central nervous system (CNS), though recent investigations have challenged this view. These highly differentiated CD8+ T cells are known to arise through TCR-dependent and TCR-independent mechanisms, such as cytokine-driven proliferation via interleukin (IL)-15. Intriguingly, chronic antigenic stimulation has been shown to drive the generation of CD8+ T cells expressing low levels of the CD8β chain, though antigen-independent mechanisms remain poorly understood. Herein, we have performed a comprehensive characterization of peripheral blood mononuclear cells (PBMC) as well as of human leukocyte antigen (HLA) molecules in a cohort of elderly volunteers differing in their cognitive status. A detailed analysis of the level of expression of CD45RA in the CD8+ TEMRA compartment revealed the presence of two distinct populations: CD8+ TEMRAlow and CD8+ TEMRAhigh cells. Notably, CD8+ TEMRAhigh cells formed a well-defined and sharply delineated population that was significantly expanded in cognitively impaired volunteers, whereas cognitively unimpaired volunteers were enriched in CD8+ TEMRAlow cells. Further analysis of CD8α and CD8β expression also identified the existence of two distinct CD8+ T cells subsets based on the expression of CD8β: CD8αβlow and CD8αβhigh T cells, with the former being more prevalent among cognitively unimpaired individuals. Moreover, stimulation with PMA and Ionomycin revealed significantly increased IFN-γ production by CD4+ T cells from cognitively impaired elderly. Noteworthy, all but one of the volunteers studied were cytomegalovirus (CMV) seropositive. Finally, a higher prevalence of the HLA-B8 serotype, which belongs to the ancestral haplotype HLA-A1, Cw7, B8, DR3, DQ2, was found among the cognitively impaired elderly. Additionally, we assessed the impact of IL-15 on the cell surface expression of CD8β using CFSE-labeled purified human naïve CD8+ T cells cultured for 12 days. IL-15 induced a robust proliferation and differentiation, resulting in a cell cycle-dependent down-modulation of CD8β from the cell surface, while CD8α expression remained stable or increased slightly. This led to the generation of CD8αβlow and CD8αβ– (i.e., CD8αα) T cells. In contrast, IL-2 and IL-7 alone were unable to replicate this effect. Determination of mRNA levels for CD8α and CD8β isoforms by qPCR revealed that IL-15 promoted a significant decrease in mRNA levels of the CD8β M-4 isoform, while increasing the levels of the M-1 and M-2 isoforms alongside with CD8α. Remarkably, analysis of the level of the tyrosine kinase Lck showed a significant increase in CD8+ T cell blasts after culture of CD8+ T cells with IL-15, when compared to CD8+ T cells at the beginning of the culture. Our findings show an association with certain CD8+ T cell subsets that is compatible with a protective role in cognition and neurodegenerative diseases by identifying novel markers that define discrete subsets of highly differentiated CD8+ T cells expanded in cognitively unimpaired elderly individuals and identify IL-15 as a factor involved in the generation of these subsets. In-depth phenotypic, functional, and transcriptomic characterization of ex vivo and in vitro obtained CD8+ T cell subset is warranted to further elucidate their unique functional properties.
Portuguese Natural Resources as Modulators of Acne Vulgaris Hallmarks
Publication . Oliveira, Ana Sofia Domingues ; Oliveira, José António Martinez Souto de; Oliveira, Ana Cristina Palmeira de; Teixeira, João Paulo Fernandes
Acne vulgaris, commonly known as acne, is a chronic skin disease of the pilosebaceous unit, that affects millions worldwide, particularly adolescents and young adults. Clinically, acne is characterized by non-inflammatory and inflammatory lesions, predominantly on the face, but also affecting the neck, chest, and upper back. Beyond its signs and symptoms, acne is also associated with a substantial psychological and emotional burden. The pathogenesis of the disease is multifactorial and involves a complex interplay of several biological events or hallmarks. Traditionally, four mechanisms have been associated with its development, namely: increased sebum production, follicular hyperproliferation/hyperkeratinization, colonization by Cutibacterium acnes bacterium (formerly Propionibacterium acnes), and the release of inflammatory mediators. However, recent research has further complicated the disease’s pathophysiology, with new factors such as changes in sebum composition, differential involvement of innate and adaptive immunity, and dysbiosis of the follicular microbiota, being increasingly described by the scientific community.
Given its multifactorial nature, different therapeutic strategies are adopted depending on the severity of the disease. Topical treatments, when used alone, are typically reserved for comedonal or non-inflammatory acne, while in combination topical therapy is considered the first-line approach for mild to moderate acne. In more severe cases, systemic treatments are used as first-line options, with isotretinoin being the standard choice despite its severe risks and side effects. These adverse effects associated with classical acne therapies, together with a behavioral shift among consumers who increasingly prefer more “natural” and/or “green” solutions, have driven both the cosmetic and pharmaceutical industries to invest in the research and development of alternatives or adjuvants to conventional treatments that meet these expectations. Plant-derived ingredients have gained particular attention and, among them, essential oils (EOs), which are secondary metabolites from aromatic plants, stand out for their spectrum of bioactive properties and are extensively used across various health fields, including dermatology.
Based on this premise, the aim of this doctoral project was to investigate the bioactive potential of preparations from aromatic and medicinal plants produced in Portugal, with a particular focus on their ability to modulate the main hallmarks involved in acne pathophysiology. Two autochthonous Portuguese species, namely Thymus mastichina (L.) L. (Thymus mastichina; TM) and Cistus ladanifer L. (Cistus ladanifer; CL), and the allochthonous hybrid Thymus × citriodorus (Pers.) Schreb. (Thymus × citriodorus; TC) were investigated for their anti-acne potential, through the study of their EOs in addition to their hydrolates, by-products of EO production, thus aligning this work with the principles of circular economy.
Initial screenings of the autochthonous taxa revealed that CL EO, rich in α-pinene, exhibited the highest anti-inflammatory potential (EC₅₀ = 0.002% v/v), although with associated cytotoxicity in murine macrophage cell model (RAW 264.7; IC₅₀ = 0.012% v/v). TM preparations, mainly composed by 1,8-cineole, showed balanced anti-inflammatory effects with superior biocompatibility in both murine macrophages and fibroblasts (L929). CL EO showed the highest antimicrobial activity, with minimum inhibitory concentrations (MICs) ranging from 0.06% (v/v) to 2% (v/v) against the tested microorganisms, which included those used in the Challenge test for cosmetics and representatives of skin microbiota.
Regarding the preparations from the allochthonous hybrid, TC EO, mainly composed of geraniol, stood out for its antimicrobial activity against acne-associated bacteria (C. acnes, Staphylococcus epidermidis and S. aureus) and for its ability to prevent and disrupt C. acnes biofilms, even at sub-inhibitory concentrations. TC hydrolate retained some bioactive potential, particularly in modulating C. acnes biofilms, still being deprived of relevant antimicrobial activity.
Considering the higher anti-acne potential of TC EO, and to address variability concerns relevant to large-scale application of EOs, four TC EOs from different Portuguese regions were compared. Although all shared geraniol as a major compound, significant differences in yield, efficacy, and cytotoxicity were observed, underscoring the need for standardization protocols. Still, all EOs exhibited antimicrobial activity, with particular effectiveness against C. acnes, as evidenced by MICs ranging from 0.016% (v/v) to 0.031% (v/v), corroborating the anti-acne potential of this hybrid.
Building upon previous results and considering the anti-acne potential of the studied preparations, their ability to modulate key acne-related events was further explored using more complex in vitro models that better mimic in vivo conditions. These closer-to-disease models further explored the preparations’ ability to modulate sebum production in human sebocytes (SZ95 cell line), C. acnes-induced inflammation and oxidative stress, keratinocyte proliferation, and bacterial adhesion. Additionally, potential antimicrobial interactions between the different preparations along with their cytotoxic and mutagenic potential were also investigated.
Regarding anti-acne efficacy, comprising the above-described models, EOs exhibited overall greater bioactivity compared to their corresponding hydrolates. The EOs of TC and CL stood out for their ability to modulate all the studied hallmarks, demonstrating a multitarget potential. Although less potent, the hydrolates still showed relevant activity, particularly the one from CL, displaying multi-target potential, failing only in inhibiting lipase activity. Regarding the combined antimicrobial activity of the preparations against C. acnes, EO–EO combinations showed consistent synergistic effects (FICIs between 0.250 and 0.375), while the presence of additive interactions depended on the specific combinations. As for safety, TC and CL EOs were the least biocompatible upon human keratinocytes and sebocytes, and all preparations were considered non-mutagenic, except for CL EO, which showed a “likely-positive” result in one of the Salmonella typhimurium strains included in the Ames test.
Based on the higher overall efficacy of the tested EOs, the final experimental work focused on potential phylotype-selective efficacy of EOs against clinical C. acnes strains, with different virulence patterns. Phylotype IA1 strains (typically associated with acne lesions), exhibited higher lipase activity and biofilm formation than phylotype II strains (more associated with healthy skin). However, not all virulence factors were phylotype-dependent, which supports the multifactorial nature of this disease. TC EO showed the lowest MICs across all strains (MICs between 0.03% v/v and 0.06% v/v) when compared to the other EOs, demonstrating less variation in MIC values between phylotypes. It was also able to reduce both biofilm biomass and metabolic activity from IA1 phylotype strains, being effective at lower concentrations. These results further support the relevance of TC EO for this application, despite its lack of phylotype-dependent selectivity.
In conclusion, this work provides evidence for the anti-acne potential of Portuguese plant preparations, particularly TC and CL EOs, supported by their capacity to modulate different pathophysiological mechanisms associated with disease development. This research also contributes to the scientific valorization of Portuguese natural resources and supports their integration into sustainable dermocosmetic formulations aligned with the principles of circular economy.
The Bridge Between Nanotechnology and Chronobiology: Circadian Control of Cancer Therapy by Gene Delivery Systems
Publication . Neves, Ana Raquel Bastos; Costa, Diana Rita Barata; Paixão, Telma Alexandra Quintela; Fan, Donglei Emma
Cancer is nowadays the second leading cause of death worldwide, making it a significant public health concern. Europe, following Asia, is, according to the Global Cancer Observatory (GLOBOCAN), the second continent where the incidence, mortality, and prevalence are highest. Statistics indicate that the number of cancer-related deaths in Europe is projected to increase 36.4% by 2050 compared to 2022. In particular, glioblastoma (GB), designated by the World Health Organization (WHO) as a grade 4 astrocytoma, represents the most prevalent (more than 50% of the total cases) and highly aggressive type of primary brain cancer in adults. This cancer is characterized by a high inter- and intratumourally genetic heterogeneity, aggressiveness, angiogenesis, invasiveness, resistance to current standard treatment protocols, poor patient prognosis (12-15 months), and low survival rate. Molecularly, several altered signalling pathways (p53 tumour suppressor pathway inclusive), gene mutations (tumour suppressor p53 gene (TP53), epidermal growth factor receptor (EGFR), isocitrate dehydrogenase (IDH)-1/2, etc.), and methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter contribute to its hyperproliferation, growth, and chemotherapeutic resistance. For these reasons, actual care treatments, as the classical Stupp protocol, face several challenges. This protocol focuses on first removing the tumour by surgical resection, without compromising the normal neurological function, followed by radiotherapy and chemotherapy with Temozolomide (TMZ), whose effectiveness depends on the MGMT gene promotor methylation status. However, after being subjected to this, patients prognosis remains very poor, and 90% of them have a tumour recurrence within two years. Thus, the development of new and more effective therapeutic approaches is essential to fight this disease. Innovative therapeutic strategies as nanotechnology, gene therapy, and chronotherapy, have been developed and explored to improve the treatment efficacy of GB. Gene therapy consists of delivering exogenous nucleic acids to cells to activate, silence, modify, or edit certain genes and correct genetic defects that may contribute to disease progression. In this case, correcting abnormal gene expression, since several mutations have been associated with glioblastoma, seems a promising approach to treat it. However, delivering nucleic acids to cells is difficult unless delivery systems are used. Nanotechnology, with the use of non-viral vectors (cell-penetrating peptides (CPPs), liposomes, polymers, exosomes, dendrimers, etc.), leads to ground-breaking possibilities for a precise delivery of anticancer drugs and nucleic acids to specific sites, overcoming several physiological barriers, as the blood-brain barrier (BBB). Targeting tumour-specific receptors using ligands at the delivery systems surface can minimize side effects and improve therapeutic responses. Additionally, in the past few years, the study of cancer cells circadian rhythms, normally disrupted, has shown that the circadian clock as a significant role in cancer development and therapeutic efficacy. Circadian rhythm is defined as the approximately 24 h oscillation of physiological and metabolic processes, which are synchronized with the Earth's diurnal cycle. Several studies indicated that rhythms could modulate drug’s effectiveness and their side effects, and delivery systems cellular uptake and efficacy. Studies have shown that some chemotherapy drugs are better tolerated or more effective at certain times of the day. Accordingly, the main object of this doctoral thesis was to design and develop a delivery system, functionalized to target glioblastoma cells, and to evaluate the influence of circadian rhythms on the efficacy of targeting, internalization, cargo release, and, ultimately, therapeutic effect for a precise cancer therapy strategy.
This approach focused on the use of a non-viral CPP, namely the WRAP5 peptide, for the construction of a delivery system bearing a transferrin (Tf) receptor ligand sequence (TfR) to co-deliver the anticancer TMZ drug and a plasmid DNA (pDNA) coding for p53 to glioblastoma cells. This system was designed to present an improved brain cell targeting ability and cellular uptake and to penetrate the brain barriers easily. The first step consisted of acquiring its physicochemical properties (size, polydisperse index, surface charge, and complexation capacity), morphology, and biocompatibility. Results revealed these properties to be under the influence of the N/P ratio, which can be optimized to improve complexes desired characteristics. These formulations demonstrated appropriate physicochemical characteristics for in vitro applications, and confocal microscopy using U87 glioblastoma cells confirmed their ability to internalize into cells and deliver the pDNA into the nucleus. Following nuclear localization, successful transcription and translation of the TP53 were observed. The resulting complexes significantly reduced the viability of glioblastoma cells. In a three-dimensional (3D) 9-day U87 spheroid model, generated by two different protocols, complexes were shown to have some effect on the spheroids morphology and size after a single dose treatment. Moreover, complexes have been revealed to be biocompatible with several non-cancerous cells and with zebrafish Danio rerio embryos. Experiments with other two glioma cell lines (SNB19 and U373) also highlighted the complexes ability for internalization and p53 expression levels increase. In these cell lines, apoptosis activation by the intrinsic pathway was implicated. This thesis also aimed to elucidate the influence of circadian core clock components in the performance of developed peptide nanocomplexes, namely, TfR expression, complexes internalization, and p53 expression promotion. The obtained results demonstrated that, at specific time-points, the highest circadian activity of Period circadian regulator 2 (PER2) and TfR led to higher cellular uptake of complexes, TP53 expression induction, and consequently p53 expression.
In summary, our comprehensive dataset provides strong evidence supporting the high potential of TMZ/TP53 co-delivery WRAP5 complexes for targeted cellular transfection, p53 expression, and for effectively triggering apoptotic pathways, holding promising therapeutic value toward glioblastoma. Moreover, aligning the timing of complexes administration with the circadian rhythms of GB cells may significantly enhance cellular uptake and gene/protein expression. This chronobiologically optimized approach offers a promising possibility for developing more precise and impactful treatment strategies against glioblastoma. Future preclinical research should prioritize the study of delivery systems bioavailability, tumour targeting, and pharmacokinetics at specific times of day in patient-derived 3D models and in vivo xenograft models. Additionally, it will be relevant to study the temporal expression of glioblastoma biomarkers and the effects of their knockout on survival and therapeutic outcomes. Understanding how brain barrier dynamics, such as permeability, for example, oscillate with circadian changes and impact delivery systems uptake, will bring noticeable improvements to this strategy. Ultimately, this research should instigate complexes clinical translation toward more effective glioblastoma therapy.
Circular entrepreneurship: Decision-making, digitalisation and small business models
Publication . Suchek, Nathalia; Ferreira, João José de Matos; Fernandes, Paula Odete
This doctoral thesis comprises five studies exploring the field of entrepreneurship within the scope of the circular economy (CE) in small businesses. The general objective of the thesis is to examine circular entrepreneurship (CEship) in the context of small firms, with the aim of generating novel insights and contributing to the development and consolidation of this research field. To this end, each of the five studies addresses a specific objective, seeking to map, understand, and explain the mechanisms through which entrepreneurs and small-scale organisations contribute to the transition towards CE.
Research on CEship remains at an early stage and is therefore somewhat fragmented. Thus, study 1 reviews the literature, mapping scientific production from 2016 to 2021, with the aim of consolidating the research field by identifying key themes, research gaps, and future directions. Based on a sample of 102 articles from Scopus and Web of Science, four thematic clusters are identified: i) growing circular SMEs, ii) born-circular firms and start-ups, iii) social entrepreneurship in CE, and iv) support ecosystems for circular entrepreneurship. The literature reveals a strong focus on growing circular SMEs, to the detriment of other groups, and is mainly concentrated on European countries. A future research agenda and a conceptual model of the entrepreneurial process in CE are proposed as a starting point for further developing and deepening the literature on circular entrepreneurship.
Study 2 extends this effort by reviewing the literature from 2021 to 2025, examining how the field has evolved, how previously identified research gaps have been addressed, and which new avenues have emerged. Using a bibliometric review with systematic lens (B-RSL), the study analyses 184 articles and reveals a marked increase in scholarly attention, reflected in a growing number of publications in high-impact journals. The field has also expanded in scope, methodological diversity, and geographical coverage. Bibliographic coupling identifies three thematic clusters: entrepreneurs, ventures, and ecosystems; growing circular firms; and theoretical models for CE adoption and digitalisation. Study 2 also evaluates progress on the research agenda set in Study 1, showing that several suggestions have been advanced, particularly in studies on start-ups, SMEs, and ecosystems. An updated agenda is proposed, highlighting gaps in areas well established in entrepreneurship research but still underexplored in CEship. Study 3 investigates how effectual and causal decision-making behaviours influence the pursuit of CE principles in small firms, while also examining the moderating role of entrepreneurial orientation (EO). Based on data from 185 Portuguese manufacturing firms and using both PLS-SEM and fuzzy-set Qualitative Comparative Analysis (fsQCA), results show that both decision-making approaches positively affect CE adoption, with effectuation exerting a stronger influence. While EO negatively moderates the relationship between causal decision-making and CE adoption, it has no significant effect on the effectuation–CE relationship. fsQCA identifies four profile of firms that follow distinct pathways to CE adoption (i.e., affordable risk firms, affordable risk entrepreneurial firms, collaborative entrepreneurial firms, and agile planning firms), showing that although causal decision-making and flexibility are consistently critical, different combinations of effectual principles (affordable loss, experimentation, pre-commitments) can also lead to high CE adoption depending on the organisational context. These findings confirm that there is no one-size-fits-all approach and that firms can successfully adopt CE through different configurations of decision-making approaches aligned with their contexts and capabilities.
Study 4 analyses the role of digitalisation through Industry 4.0 (I4.0) technologies and participation in global value chains (GVCs), as well as the effects of their complementarity on CE adoption by SMEs. Drawing on the resource-based view (RBV), the study considers I4.0 technologies and GVC participation as key resources for CE. Using a large international sample, logistic and linear regression models were employed to test hypotheses on the effects of I4.0 technologies, GVC participation, and their interaction on CE actions (e.g., recycling or reusing materials, reducing the consumption and impact of natural resources, saving energy and/or switching to sustainable sources, and developing sustainable products or services). Findings suggest that I4.0 technologies already play an important role in CE adoption, and SMEs engaged in GVCs are more likely to adopt CE actions. However, results also indicate that combining these two resources may sometimes be detrimental, particularly in relation to recycling and reusing materials, saving energy, and the widespread adoption of CE practices. The study, therefore, offers new insights into the complexities of resource complementarity in SMEs’ pursuit of CE.
Study 5 examines how social logics are embedded in the business models of circular ventures by analysing the relationship between commitment to social logic and the degree of entrepreneurial newness. Drawing on institutional logics and hybrid organisations literature, a qualitative approach was applied to 42 Portuguese circular ventures. Thematic analysis identified six patterns of social logic incorporation (ethical value chains, valorisation of local communities, community education and engagement, value sharing, democratised access to products, and social inclusion), mapped across the dimensions of value proposition, creation, delivery, and capture. These were then associated with ventures’ market and technological newness, leading to the identification of seven profiles reflecting different forms of hybridity. Findings suggest that social logic is more explicit in ventures with low market and technological newness, as well as those with high technological newness focused on extending resource value. The results underline the heterogeneity of circular business models and highlight the dual role of social logic as both a strategic positioning mechanism and a source of legitimacy under conditions of institutional pluralism.
Taken together, the five studies provide original contributions to CEship research, particularly in the context of small businesses. The results advance the theoretical consolidation of this emerging field by applying diverse methodological approaches and theoretical lenses. They also offer relevant practical implications for entrepreneurs, SME managers, and policymakers seeking to accelerate the transition towards more resilient and sustainable business models. The thesis, therefore, demonstrates the potential of small firms to drive circular transformation, turning entrepreneurial practices into engines of resilience and systemic change.
Obesogens-induced deregulation of periprostatic adipose tissue: a driven force in the onset and progression of prostate cancer?
Publication . Feijó, Mariana Pombal ; Socorro, Sílvia Cristina da Cruz Marques; Correia, Sara Carina de Lima; Kiss-Tóth, Endre
Prostate cancer (PCa) is a hormone-dependent cancer whose development and progression are strongly influenced by the tumour microenvironment and exogenous factors, such as environmental influences. The periprostatic adipose tissue (PPAT), by its anatomical proximity and functional crosstalk with prostate cells, emerged as a key driver of tumour growth, particularly in obesity, with the secretome of “obese” PPAT being associated with enhanced tumour aggressiveness. On the other hand, epidemiological and experimental studies have implicated endocrine-disrupting chemicals (EDCs) as environmental risk factors for PCa.
Given the hormone dependency of PCa, it is predictable that it is a cancer highly susceptible to the influence of environmental exposures, namely EDCs and specifically those with obesogenic properties (i.e. obesogens), which are capable of disrupting both endocrine and metabolic pathways. Notably, based on their mechanisms of action and the cellular and molecular alterations they induce, obesogens may promote tumorigenesis either directly by acting on prostate cells or indirectly by inducing adipose tissue dysfunction. However, the extent to which obesogenic compounds drive these alterations and the consequent impact on prostate tumorigenesis remain largely unknown. Moreover, despite the well-established effects of obesogens on adipose tissue, no study has characterised their actions on PPAT. Addressing these gaps is critical to understanding how environmental factors intersect with adipose tissue biology, influencing interorgan communication between the prostate and adipose tissue and PCa development. Based on this scientific rationale, this doctoral thesis hypothesises that obesogen-induced PPAT dysfunction represents a driving force in the initiation and progression of PCa.
Tributyltin (TBT) is a well-characterised obesogenic EDC and a potent regulator of adipogenesis, widely used in experimental settings to investigate the effects of obesogens. Therefore, using the obesogen model TBT this thesis aimed to: (i) characterise the morphological and secretory alterations of PPAT following TBT exposure; (ii) assess the impact of TBT-induced PPAT dysregulation on prostate cell fate, metabolism, oxidative and inflammatory status, and response to chemotherapeutic drugs; and (iii) identify the molecular targets and signalling pathways mediating the crosstalk between dysregulated PPAT and prostate cells.
First, it was demonstrated that in vivo exposure to TBT (50 μg/kg) besides increasing rat body weight, enhanced PPAT somatic index and altered its functional phenotype. TBT treatment promoted a shift in rat prostate cells toward a glycolytic and lipogenic metabolic profile and stimulated oncogenic signalling pathways, including increased phosphorylated/total protein kinase B (pAKT/AKT) ratio and androgen receptor expression. Moreover, macrophage infiltration and a shift in macrophage polarisation towards a pro-inflammatory phenotype were observed both in the prostate and PPAT of TBT-exposed animals, suggesting that TBT can perturb the local prostate-PPAT immune status, contributing to an environment permissive to prostate carcinogenesis. These findings confirmed the effects of TBT on prostate cells, supporting the hypothesis and the investigation into the contribution of PPAT-mediated effects in altering prostate cell behaviour.
Culture of the PPAT from rats exposed to TBT clearly demonstrated that TBT induced a dysregulation of the PPAT secretome. TBT-treated PPAT (TBT-PPAT) displayed increased leptin/adiponectin ratio and C-C motif chemokine ligand 7 (CCL7) levels. This adipokine/chemokine profile induced by TBT mimics that observed in obesity and is concurrent with a metabolic reprogramming associated with enhanced glucose, free fatty acids, and lipid peroxidation.
Importantly, ex vivo exposure of rat PPAT to TBT (100 nM) recapitulated the findings obtained in vivo concerning the features of its secretome, which are capable of having an impact on prostate cell fate.
The results obtained in the subsequent preclinical approaches using co-cultures and conditioned media (CM) assays confirmed the ability of TBT-PPAT enhance the viability, proliferation and migration, as well as apoptosis resistance, in all the studied prostate cell line models, namely non-neoplastic prostate epithelial cells (PNT1A), and androgen-sensitive (22Rv1) and androgen-insensitive (DU145 and PC3) PCa cells.
Notably, the TBT-PPAT secretome increased the expression of CCL7 receptor, the C-C motif receptor 3 (CCR3), in prostate cells, which, together with the enhanced CCL7 secretion observed in our experimental setting, raised curiosity about the role of the CCL7-CCR3 axis underlying the pro-tumorigenic effects of TBT-PPAT. The use of a CCR3 antagonist significantly reduced TBT-PPAT induced migration across all cell lines, allowing to implicate the CCL7 and CCR3 in the observed responses of prostate cells. Other molecular targets beyond the CCL7-CCR3 axis were also highlighted. It is the case of tribbles homolog 1 (TRIB1), a pseudokinase involved in tumorigenesis and lipid homeostasis that was overexpressed across all studied cell models exposed to TBT-PPAT-CM.
Cell fate alterations observed upon TBT treatment were accompanied by metabolic changes with distinct outcomes in non-neoplastic and neoplastic cell lines: in PNT1A, enhanced fatty acid β-oxidation and synthesis indicate a plausible shift toward a cancer-like metabolic profile; in 22Rv1, the unaltered metabolic and oxidative status suggests the activation of alternative signalling pathways sustaining TBT-PPAT effects; in DU145 and PC3, the distinct metabolic responses observed underscore the differential responsiveness of androgen-insensitive PCa cell subtypes to adipose-derived cues.
The investigation in the present thesis was extended to a clinically relevant setting. Human PPAT obtained from patients submitted to radical prostatectomy or prostatic adenomectomy (Millin’s procedure) was treated ex vivo with TBT (100 nM) to confirm if the human tissues resemble the pro-tumorigenic cues identified in controlled experimental models. This approach demonstrated that human PPAT is a target of obesogenic dysregulation and showed that the secretome of obesogen-dysregulated PPAT can significantly enhance the viability of prostate cells. Moreover, the presence of human TBT-PPAT reduced the sensitivity of PCa cells to docetaxel and cabazitaxel, suggesting that obesogenic dysregulation contributes to PCa resistance to taxane-based chemotherapy.
Overall, the scientific evidence gathered in this thesis identifies PPAT as a key target of obesogenic EDCs, which disrupt PPAT function and its crosstalk with prostate cells, thereby contributing to the initiation and progression of PCa. These findings open new avenues for developing interventions aimed at modulating PPAT activity to counteract its tumour-promoting effects and emphasise obesity as a critical modulator of PCa aggressiveness.